目的 HyperCVAD 强力化疗方案治疗血液系统恶性肿瘤近年来在国外报道日渐增多,文献显示疗效显著而且耐受性良好,但是在中国缺乏大宗病例报道,故本研究欲探讨该方案治疗我国急性淋巴细胞白血病、恶性淋巴瘤等血液系统肿瘤的疗效和可能的毒副反应。方法 2004年9月至2007年2月,我院血液科采用 HyperCVAD 化疗方案治疗初治急性淋巴细胞白血病、高度侵袭性恶性淋巴瘤及 Objective HyperCVAD powerful chemotherapy for the treatment of hematological malignancies in foreign countries reported increasing in recent years, the literature shows a significant effect and well tolerated, but the lack of a large number of cases reported in China, so this study would like to explore the program for the treatment of acute lymphoblastic leukemia in our country, Malignant lymphoma and other hematological malignancies and possible side effects. Methods From September 2004 to February 2007, the department of hematology in our hospital used HyperCVAD chemotherapy to treat newly diagnosed acute lymphoblastic leukemia and highly aggressive malignant lymphoma